Haanen J, Mackensen A, Koenecke C, Alsdorf W, Desuki A, Wagner-Drouet E, Heudobler D, Borchmann P, Wiegert E, Schulz C, Rengstl B, Preussner L, Tuereci O, Sahin U (2021)
Publication Type: Conference contribution
Publication year: 2021
Publisher: ELSEVIER
City/Town: AMSTERDAM
Pages Range: S1392-S1392
Conference Proceedings Title: ANNALS OF ONCOLOGY
DOI: 10.1016/j.annonc.2021.10.216
APA:
Haanen, J., Mackensen, A., Koenecke, C., Alsdorf, W., Desuki, A., Wagner-Drouet, E.,... Sahin, U. (2021). BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors. In ANNALS OF ONCOLOGY (pp. S1392-S1392). AMSTERDAM: ELSEVIER.
MLA:
Haanen, J., et al. "BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors." Proceedings of the ANNALS OF ONCOLOGY AMSTERDAM: ELSEVIER, 2021. S1392-S1392.
BibTeX: Download